Logo

NuGen, Qiagen Pen Collaboration for RNA Amplification, Analysis

May 03, 2006

NEW YORK, May 3 (GenomeWeb News) - NuGen Technologies and Qiagen have penned a co-marketing alliance to create a series of joint applications for RNA amplification and analysis.

 

The agreement is aimed at providing researchers with the means to isolate, amplify, fragment, and label RNA for research and molecular diagnostic ends.

 

Details of the deal were not disclosed.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.